Jukka Lehtonen

8.7k total citations · 3 hit papers
79 papers, 4.2k citations indexed

About

Jukka Lehtonen is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Jukka Lehtonen has authored 79 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Cardiology and Cardiovascular Medicine, 35 papers in Molecular Biology and 35 papers in Physiology. Recurrent topics in Jukka Lehtonen's work include Sarcoidosis and Beryllium Toxicity Research (32 papers), Viral Infections and Immunology Research (24 papers) and Lipid Membrane Structure and Behavior (19 papers). Jukka Lehtonen is often cited by papers focused on Sarcoidosis and Beryllium Toxicity Research (32 papers), Viral Infections and Immunology Research (24 papers) and Lipid Membrane Structure and Behavior (19 papers). Jukka Lehtonen collaborates with scholars based in Finland, United States and France. Jukka Lehtonen's co-authors include Paavo K.J. Kinnunen, Markku Kupari, Riina Kandolin, Laurent Daviet, Juha M. Holopainen, Masatsugu Horiuchi, Victor J. Dzau, Leslie T. Cooper, Kaisa Salmenkivi and Stéphane Heymans and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Circulation.

In The Last Decade

Jukka Lehtonen

78 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy

2020 440 citations Jukka Lehtonen et al. profile →
Cardiac Sarcoidosis

2014 379 citations Riina Kandolin, Jukka Lehtonen et al. Circulation profile →
Cardiac sarcoidosis: phenotypes, diagnosis, treatment, and prognosis

2023 90 citations Jukka Lehtonen, Valtteri Uusitalo et al. European Heart Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jukka Lehtonen Finland	37	1.7k	1.7k	1.4k	1.0k	488	79	4.2k
Yuhui Xu China	21	1.1k 0.6×	1.5k 0.9×	300 0.2×	186 0.2×	223 0.5×	44	3.0k
Eric J. Smart United States	35	849 0.5×	3.9k 2.3×	1.5k 1.1×	163 0.2×	1.5k 3.0×	56	7.0k
Christian Schudt Germany	37	605 0.3×	2.5k 1.5×	1.4k 1.0×	1.0k 1.0×	290 0.6×	81	4.0k
Marc Goethals Belgium	34	1.5k 0.9×	1.9k 1.1×	368 0.3×	207 0.2×	471 1.0×	105	4.5k
Roberto Pacelli Italy	36	282 0.2×	949 0.6×	827 0.6×	688 0.7×	315 0.6×	123	3.8k
Athan Kuliopulos United States	48	1.0k 0.6×	2.9k 1.7×	215 0.1×	275 0.3×	416 0.9×	94	6.6k
Andrew A. Grace United Kingdom	43	4.0k 2.3×	3.2k 1.9×	207 0.1×	273 0.3×	457 0.9×	184	5.8k
Anne M. Murphy United States	36	2.4k 1.4×	2.2k 1.3×	256 0.2×	637 0.6×	679 1.4×	108	4.7k
Béla Nagy Hungary	30	552 0.3×	1.1k 0.6×	218 0.2×	304 0.3×	231 0.5×	120	2.7k
Paula Sherman United States	21	560 0.3×	1.1k 0.7×	1.4k 1.0×	139 0.1×	142 0.3×	34	3.4k

Countries citing papers authored by Jukka Lehtonen

Since Specialization

Citations

This map shows the geographic impact of Jukka Lehtonen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jukka Lehtonen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jukka Lehtonen more than expected).

Fields of papers citing papers by Jukka Lehtonen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jukka Lehtonen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jukka Lehtonen. The network helps show where Jukka Lehtonen may publish in the future.

Co-authorship network of co-authors of Jukka Lehtonen

This figure shows the co-authorship network connecting the top 25 collaborators of Jukka Lehtonen. A scholar is included among the top collaborators of Jukka Lehtonen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jukka Lehtonen. Jukka Lehtonen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pöyhönen, Pauli, Jukka Lehtonen, Piia Simonen, et al.. (2024). End-Stage Heart Failure in Cardiac Sarcoidosis. Circulation. 149(11). 885–887. 3 indexed citations

Pöyhönen, Pauli, Jukka Lehtonen, Suvi Syväranta, et al.. (2024). Magnetic Resonance Imaging in the Assessment of the Risk of Sudden Death in Cardiac Sarcoidosis: What Is Extensive or Significant Late Gadolinium Enhancement?. Circulation Arrhythmia and Electrophysiology. 18(1). e013239–e013239. 6 indexed citations

Lehtonen, Jukka, et al.. (2023). Health-Related Quality of Life Among Transthyretin Amyloid Cardiomyopathy Patients. ESC Heart Failure. 10(3). 1871–1882. 12 indexed citations

Pöyhönen, Pauli, Mikko I. Mäyränpää, Hanna‐Kaisa Nordenswan, et al.. (2023). Cardiac magnetic resonance in histologically proven eosinophilic myocarditis. Journal of Cardiovascular Magnetic Resonance. 25(1). 79–79. 4 indexed citations

Pöyhönen, Pauli, Hanna‐Kaisa Nordenswan, Jukka Lehtonen, et al.. (2023). Cardiac magnetic resonance in giant cell myocarditis: a matched comparison with cardiac sarcoidosis. European Heart Journal - Cardiovascular Imaging. 24(4). 404–412. 17 indexed citations

Nordenswan, Hanna‐Kaisa, Pauli Pöyhönen, Jukka Lehtonen, et al.. (2022). Incidence of Sudden Cardiac Death and Life-Threatening Arrhythmias in Clinically Manifest Cardiac Sarcoidosis With and Without Current Indications for an Implantable Cardioverter Defibrillator. Circulation. 146(13). 964–975. 49 indexed citations

Bollano, Entela, Christian L. Polte, Mikko I. Mäyränpää, et al.. (2022). Cardiac Sarcoidosis and Giant Cell Myocarditis After COVID-19 Infection. ESC Heart Failure. 9(6). 4298–4303. 8 indexed citations

Nordenswan, Hanna‐Kaisa, Jukka Lehtonen, Kaj Ekström, et al.. (2021). Manifestations and Outcome of Cardiac Sarcoidosis and Idiopathic Giant Cell Myocarditis by 25‐Year Nationwide Cohorts. Journal of the American Heart Association. 10(6). e019415–e019415. 33 indexed citations

Bobbio, Emanuele, Bright I. Nwaru, Eva Hessman, et al.. (2020). Inflammatory cardiomyopathies: short- and long-term outcomes after heart transplantation—a protocol for a systematic review and meta-analysis. Heart Failure Reviews. 25(3). 481–485. 2 indexed citations

10.

Kandolin, Riina, et al.. (2017). 1961Infliximab in cardiac sarcoidosis. European Heart Journal. 38. 1 indexed citations

11.

Kandolin, Riina, Jukka Lehtonen, Juhani Airaksinen, et al.. (2015). Usefulness of Cardiac Troponins as Markers of Early Treatment Response in Cardiac Sarcoidosis. The American Journal of Cardiology. 116(6). 960–964. 45 indexed citations

12.

Backlund, Michael, Kirsi Paukku, Laurent Daviet, et al.. (2009). Posttranscriptional regulation of angiotensin II type 1 receptor expression by glyceraldehyde 3-phosphate dehydrogenase. Nucleic Acids Research. 37(7). 2346–2358. 42 indexed citations

13.

Lehtonen, Jukka, Kirsi Paukku, Laurent Daviet, & Kimmo Kontula. (2006). Abstract 1037: Angiotensin II Type 1 Receptor 1166 Polymorphism A -> C Increases mRNA Stability and Steady-State Levels. Circulation. 114(2). 16–9. 1 indexed citations

14.

Lehtonen, Jukka, Laurent Daviet, Clara Nahmias, Masatsugu Horiuchi, & Victor J. Dzau. (1999). Analysis of Functional Domains of Angiotensin II Type 2 Receptor Involved in Apoptosis. Molecular Endocrinology. 13(7). 1051–1060. 61 indexed citations

15.

Akishita, Masahiro, Masaaki Ito, Jukka Lehtonen, et al.. (1999). Expression of the AT2 receptor developmentally programs extracellular signal-regulated kinase activity and influences fetal vascular growth. Journal of Clinical Investigation. 103(1). 63–71. 83 indexed citations

16.

Lehtonen, Jukka, et al.. (1999). Signaling Mechanism of the AT2 Angiotensin II Receptor: Crosstalk between AT1 and AT2 Receptors in Cell Growth. Trends in Endocrinology and Metabolism. 10(10). 391–396. 53 indexed citations

17.

Lehtonen, Jukka, Juha M. Holopainen, & Paavo K.J. Kinnunen. (1996). Evidence for the formation of microdomains in liquid crystalline large unilamellar vesicles caused by hydrophobic mismatch of the constituent phospholipids. Biophysical Journal. 70(4). 1753–1760. 70 indexed citations

18.

Lehtonen, Jukka, Juha M. Holopainen, & Paavo K.J. Kinnunen. (1996). Activation of Phospholipase A₂ by Amyloid β-Peptides in Vitro. Biochemistry. 35(29). 9407–9414. 53 indexed citations

19.

Lehtonen, Jukka, Marjatta Rytömaa, & Paavo K.J. Kinnunen. (1996). Characteristics of the binding of tacrine to acidic phospholipids. Biophysical Journal. 70(5). 2185–2194. 17 indexed citations

20.

Lehtonen, Jukka & Paavo K.J. Kinnunen. (1995). Phospholipase A2 as a mechanosensor. Biophysical Journal. 68(5). 1888–1894. 123 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact